PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Aqueous extract (250 mg/kg) in rats ameliorated streptozotocin-induced diabetes via anti-inflammatory pathways and enhanced insulin function [PMID:31579450]. Lupeol from leaves showed α-amylase inhibition in vitro [PMID:39842236].
Ethanolic seed extract demonstrated antitumour activity against DMBA-induced breast cancer in rats [PMID:32913391].
Extract inhibited allergic responses and 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice [PMID:30609435].
Heartwood methanolic extract (250mg/kg) provided protective effects against alcohol-induced oxidative/nitrosative liver damage in rats [PMID:27544549].
Intranasal essential oil (20 mg/kg) reversed social withdrawal and behavioral impairments in social defeat stress-exposed mice [PMID:38242042].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 27041873 (2016) — Therapeutic Potential of Pterocarpus santalinus L.: An Update. · Pharmacognosy reviews
- 2.PMID: 33801098 (2021) — Pterostilbene in Cancer Therapy. · Antioxidants (Basel, Switzerland)
- 3.PMID: 39701747 (2024) — [Textual research on Zitan]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
- 4.PMID: 33915135 (2021) — Traditional uses, phytochemistry and pharmacological attributes of Pterocarpus santalinus and future directions: A review. · Journal of ethnopharmacology
- 5.PMID: 32913391 (2020) — Antitumour Property of Pterocarpus santalinus Seeds Against DMBA-Induced Breast Cancer in Rats.